Noninvasive low-grade papillary urothelial carcinoma with degenerative nuclear atypia: a grading pitfall

被引:2
|
作者
Matoso, Andres [1 ,2 ,3 ,4 ]
Parimi, Vamsi [1 ]
Epstein, Jonathan I. [1 ,2 ,3 ,4 ]
机构
[1] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21231 USA
[2] Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21231 USA
[3] Johns Hopkins Med Inst, Dept Oncol, Baltimore, MD 21231 USA
[4] Johns Hopkins Greenberg Bladder Canc Inst, Baltimore, MD 21231 USA
关键词
Bladder cancer; Papillary urothelial carcinoma; Grade; Degenerative atypia; Ki67; INVASIVE BLADDER-CANCER; PROGRESSION; RECURRENCE; MUTATIONS; UPDATE; NERVE;
D O I
10.1016/j.humpath.2021.04.002
中图分类号
R36 [病理学];
学科分类号
100104 ;
摘要
Noninvasive low-grade papillary urothelial carcinoma is a papillary neoplasm with orderly appearance and mild nuclear pleomorphism. Some cases show significant nuclear pleomorphism with degenerative atypia leading to grading difficulties. A retrospective review of the pathology files identified 16 cases diagnosed as noninvasive low-grade papillary urothelial carcinoma with degenerative atypia. Fifteen cases were consults. The average age was 46 years (range 19-78). The average size was 1.7 cm (range: 0.3-3.5). The submitting diagnoses in consults were noninvasive high-grade papillary urothelial carcinoma (n = 6), condyloma (n = 1), atypical papillary lesion (n = 1), prominent umbrella cells (n = 1), and not given (n = 6). Ki-67 proliferation rate was <5% in 10 of 10 cases (100%), and the cells with large atypical nuclei were negative. Microscopically, there were scattered cells with nuclei larger than 5 times the size of stromal lymphocytes but displayed smudgy chromatin and occasional multinucleation and intranuclear vacuoles. Next-generation sequencing identified the following mutations: HRAS (n = 4), FGFR3 (n = 3), KRAS (n = 3), BRAF (n = 1), PDGFRA (n = 1), and PIK3CA (n = 1). Other deleterious mutations were identified, but none in genes characteristic of high-grade tumors. Follow-up was available in 6 patients (median 32 months). One patient recurred with a noninvasive low-grade papillary urothelial carcinoma 20 months after the index case. All the remaining patients had no evidence of disease at the last follow-up. No patient died or had disease progression. The combination of preservation of polarity, low mitotic activity, Ki-67 <5% with the larger atypical nuclei negative for Ki-67, along with nuclear atypia that is degenerative are features used to classify these tumors as low grade. (C) 2021 Elsevier Inc. All rights reserved.
引用
收藏
页码:1 / 8
页数:8
相关论文
共 50 条
  • [21] Noninvasive papillary urothelial carcinoma with pathological features in between low and high grades A case report
    Ma, Shuang
    Han, Yang
    Zhang, Di
    Li, Qingchang
    Wang, Enhua
    Wu, Guangping
    Zhao, Huanyu
    MEDICINE, 2021, 100 (17) : E25693
  • [22] Mitotic activity in noninvasive papillary urothelial carcinoma: its value in predicting tumor recurrence and comparison with the contemporary 2-tier grading system
    Zaleski, Michael
    Gogoj, Augustyna
    Walter, Vonn
    Raman, Jay D.
    Kaag, Matthew
    Merrill, Suzanne B.
    Drabick, Joseph
    Joshi, Monika
    Holder, Sheldon
    DeGraff, David J.
    Warrick, Joshua, I
    HUMAN PATHOLOGY, 2019, 84 : 275 - 282
  • [23] Immunohistochemical study in the grading of non-muscle-invasive papillary urothelial carcinoma of the bladder
    Pugachev, V. V.
    Gorban, N. A.
    Safiullin, K. N.
    Karyakin, O. B.
    ONKOUROLOGIYA, 2014, 10 (03): : 49 - 53
  • [24] Recurrence and progression in low grade papillary urothelial tumors
    Holmäng, S
    Hedelin, H
    Anderström, C
    Holmberg, E
    Busch, C
    Johansson, SL
    JOURNAL OF UROLOGY, 1999, 162 (03): : 702 - 707
  • [25] Correlation of tumor-infiltrating lymphocytes with bladder cancer recurrence in patients with solitary low-grade urothelial carcinoma
    Krpina, Kristian
    Babarovic, Emina
    Jonjic, Nives
    VIRCHOWS ARCHIV, 2015, 467 (04) : 443 - 448
  • [26] Mixed low- and high-grade papillary urothelial carcinoma: histopathogenetic and clinical significance
    Mai, Kien T.
    Flood, Trevor A.
    Williams, Phillip
    Kos, Zuzana
    Belanger, Eric C.
    VIRCHOWS ARCHIV, 2013, 463 (04) : 575 - 581
  • [27] A transcriptional network of cell cycle dysregulation in noninvasive papillary urothelial carcinoma
    Warrick, Joshua I.
    Knowles, Margaret A.
    Hurst, Carolyn D.
    Shuman, Lauren
    Raman, Jay D.
    Walter, Vonn
    Putt, Jeffrey
    Dyrskjot, Lars
    Groeneveld, Clarice
    Castro, Mauro A. A.
    Robertson, A. Gordon
    DeGraff, David J.
    SCIENTIFIC REPORTS, 2022, 12 (01)
  • [28] Cytopathologic differential diagnosis of low-grade urothelial carcinoma and reactive urothelial proliferation in bladder washings: a logistic regression analysis
    Cakir, Ebru
    Kucuk, Ulku
    Pala, Emel Ebru
    Sezer, Ozlem
    Ekin, Rahmi Gokhan
    Cakmak, Ozgur
    APMIS, 2017, 125 (05) : 431 - 436
  • [29] FGFR3 mutations and a normal CK20 staining pattern define low-grade noninvasive urothelial bladder tumours
    van Oers, Johanna M. M.
    Wild, Peter J.
    Buryer, Maximilian
    Denzinger, Stefan
    Stoehr, Robert
    Rosskopf, Elke
    Hofstaedter, Ferdinand
    Steyerberg, Ewout W.
    Klinkhammer-Schalkef, Monika
    Zwarthoff, Ellen C.
    van der Kwast, Theodorus H.
    Hartmann, Arndt
    EUROPEAN UROLOGY, 2007, 52 (03) : 760 - 768
  • [30] Loss of heterozygosity at 9q32-33 (DBC1 locus) in primary non-invasive papillary urothelial neoplasm of low malignant potential and low-grade urothelial carcinoma of the bladder and their associated normal urothelium
    Lopez-Beltran, A.
    Alvarez-Kindelan, J.
    Luque, R. J.
    Blanca, A.
    Quintero, A.
    Montironi, R.
    Cheng, L.
    Gonzalez-Campora, R.
    Requena, M. J.
    JOURNAL OF PATHOLOGY, 2008, 215 (03): : 263 - 272